Neurology

Research questions whether reducing sodium intake could reduce the risk of developing multiple sclerosis.

Fingolimod shows 82% efficacy reducing the annualized multiple sclerosis relapse rate.

A look at last week's top stories in the world of pharmacy.

Top news of the week from Specialty Pharmacy Times.

Combination therapy found to reverse multiple sclerosis in mice models.

A look at last week's top stories in the world of pharmacy.

MRIs show brain changes related to multiple sclerosis before symptom onset.

The presence of certain bacteria could result in worsening of multiple sclerosis.

Allergy medication may cause remyelination in humans with multiple sclerosis.

Top news of the week from Specialty Pharmacy Times.

An estimated 75% of patients with multiple sclerosis report fatigue among their most disabling disease symptoms.

A lack of biomarkers can result in a delay in multiple sclerosis diagnosis and treatment.

The grant from the National Multiple Sclerosis Society aims to support the development of a potential oral treatment for progressive forms of MS.

Several drugs are in the pipeline for the treatment of specialty conditions, including cancer and multiple sclerosis.

Top news of the day from across the health care landscape.

Two different Copaxone injection doses approved for relapsing forms of multiple sclerosis.

Top news of the day from across the health care landscape.

The neurodegenerative phase of multiple sclerosis remains a significant challenge for researchers.

New classes of multiple sclerosis medications are improving on disease suppression.

Mice treated prophylactically were protected from developing multiple sclerosis and neurological deficits.

Inhibiting cytokines could prevent disease progression among those with multiple sclerosis.

An examination of payer coverage for multiple sclerosis drugs shows variation in how these drugs are covered and in the evidence that payers review to make these decisions.

Findings further strengthen the need to protect young people from head injury.

Dietary studies for patients with multiple sclerosis have centered on vitamin D and obesity, but not overall diets.

Fingolimod may reduce relapses more effectively than interferon beta-1a in pediatric multiple sclerosis.